BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34567803)

  • 21. A retrospective study of definitive chemoradiotherapy in patients with resectable small cell neuroendocrine carcinoma of the esophagus.
    Katada C; Komori S; Yoshida T; Kawakami S; Watanabe A; Ishido K; Azuma M; Wada T; Hosoda K; Yamashita K; Hiki N; Tanabe S; Ishiyama H; Koizumi W
    Esophagus; 2020 Apr; 17(2):135-140. PubMed ID: 31321580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study.
    Ishikawa M; Kasamatsu T; Tsuda H; Fukunaga M; Sakamoto A; Kaku T; Nakanishi T; Hasumi Y; Iwata T; Baba T; Nogawa T; Kudaka W; Kaneda H; Ono S; Saito F; Taniguchi Y; Okada S; Mizuno M; Onda T; Yaegashi N
    Gynecol Oncol; 2018 Jan; 148(1):139-146. PubMed ID: 29113721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
    Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
    [No Abstract]   [Full Text] [Related]  

  • 24. Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study.
    Lee SW; Nam JH; Kim DY; Kim JH; Kim KR; Kim YM; Kim YT
    Int J Gynecol Cancer; 2010 Apr; 20(3):411-6. PubMed ID: 20375806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large-cell neuroendocrine carcinoma of the uterine cervix--a clinicopathological study of five cases.
    Rhemtula H; Grayson W; van Iddekinge B; Tiltman A
    S Afr Med J; 2001 Jun; 91(6):525-8. PubMed ID: 11455720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypes.
    Ishikawa M; Kasamatsu T; Tsuda H; Fukunaga M; Sakamoto A; Kaku T; Kato T; Takahashi K; Ariyoshi K; Suzuki K; Arimoto T; Matsumoto Y; Nakai H; Inoue T; Yokoyama M; Kawabata T; Kodama S; Miyamoto T; Takano M; Yaegashi N
    Gynecol Oncol; 2019 Dec; 155(3):444-451. PubMed ID: 31635755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
    Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
    Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.
    Lee SW; Lim KT; Bae DS; Park SY; Kim YT; Kim KR; Nam JH
    Gynecol Obstet Invest; 2015; 79(3):172-8. PubMed ID: 25500455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence.
    Viswanathan AN; Deavers MT; Jhingran A; Ramirez PT; Levenback C; Eifel PJ
    Gynecol Oncol; 2004 Apr; 93(1):27-33. PubMed ID: 15047210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Dilemma: Prognostic Factors and Outcome for Neuroendocrine Tumors of the Cervix.
    Abdallah R; Bush SH; Chon HS; Apte SM; Wenham RM; Shahzad MM
    Int J Gynecol Cancer; 2016 Mar; 26(3):553-60. PubMed ID: 26825841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I-IV Stage.
    Lowczak A; Kolasinska-Cwikla A; Osowiecka K; Glinka L; Palucki J; Rzepko R; Doboszynska A; Cwikla JB
    Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33525370
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
    Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW
    World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis.
    Höckel M; Hentschel B; Horn LC
    Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Factors and Impact of Minimally Invasive Surgery in Early-stage Neuroendocrine Carcinoma of the Cervix.
    Kim JH; Shim SH; Nam SH; Lee SW; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT
    J Minim Invasive Gynecol; 2020; 27(7):1558-1565. PubMed ID: 32084588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodality treatment for poorly differentiated neuroendocrine head and neck carcinomas--a single institution experience.
    Görner M; Brasch F; Hirnle P; Gehl HB; Scholtz LU; Wegehenkel K; Sudhoff H
    Eur J Cancer Care (Engl); 2013 Sep; 22(5):648-52. PubMed ID: 23701280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oncologic Outcomes of Stage IVB or Persistent or Recurrent Cervical Carcinoma Patients Treated With Chemotherapy at Siriraj Hospital: Thailand's Largest Tertiary Referral Center.
    Ruengkhachorn I; Leelaphatanadit C; Therasakvichya S; Hunnangkul S
    Int J Gynecol Cancer; 2016 Jul; 26(6):1154-61. PubMed ID: 27051060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large cell neuroendocrine carcinoma of the cervix: prognostic factors and survival advantage with platinum chemotherapy.
    Embry JR; Kelly MG; Post MD; Spillman MA
    Gynecol Oncol; 2011 Mar; 120(3):444-8. PubMed ID: 21138780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy.
    Mabuchi S; Okazawa M; Kinose Y; Matsuo K; Fujiwara M; Suzuki O; Morii E; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2012 Oct; 22(8):1389-97. PubMed ID: 22976497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel and carboplatin for large cell neuroendocrine carcinoma of the uterine cervix.
    Tangjitgamol S; Manusirivithaya S; Choomchuay N; Leelahakorn S; Thawaramara T; Pataradool K; Suekwatana P
    J Obstet Gynaecol Res; 2007 Apr; 33(2):218-24. PubMed ID: 17441901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemoradiotherapy in locally advanced cancers of the uterine neck. Retrospective study of 92 patients treated at the Institute Curie between 1986 and 1998]].
    Nguyen D; de la Rochefordière A; Chauveinc L; Cosset JM; Clough KB; Beuzeboc P; Mouret-Fourme E; Guyonnet M
    Cancer Radiother; 2002 Jun; 6(4):201-8. PubMed ID: 12224486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.